A class of anticancer drugs that target TOP2, termed TOP2 poisons, including etoposide (VP-16)8, teniposide (VM-26)6, doxorubicin (DOX)9, and mitoxantrone10, are widely used and rather effective in clinical cancer treatment. The gene discussed is TOP2A; the disease is cancer.